# Cellebrite DI Ltd. share price today (Cellebrite DI Ltd., CLBT)

> Cellebrite DI Ltd.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. CLBT · Technology · Software - Infrastructure · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/clbt

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $12.25 (−28.2% in a year)
- P/E: 53.4× (higher than 61% of the last 4.6 years)
- Revenue (Jun 2026): $131 M (+15.8% on a year ago)
- Profit (Jun 2026): $6.4 M (−67.3% on a year ago)
- Operating margin: 5.3% (−7.4 points on a year ago)
- ROE: 16%, FY25
- ROIC: 39.0%, against a 10.4% cost of capital: +28.6 points
- Profit that came in as cash: 87%, last 3 years

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Cellebrite DI Ltd. share price today? Cellebrite DI Ltd.'s share price was $12.25 at the close on 3 November 2026. It has been falling for 13 weeks. That is 8.2% below its average price over the last 200 trading days. In the last 52 weeks it traded between $11 and $19, and at that close it sat 17% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 13 weeks running. Over the last 6 years the share price moved +26% while the S&P 500 moved +111%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 7 August 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Cellebrite DI Ltd. pay? Cellebrite DI Ltd. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Cellebrite DI Ltd. on? Cellebrite DI Ltd. is on one of our US lists: US tech stocks. [US tech stocks](https://www.sectoralpha.in/us-tech-stocks)

## Is Cellebrite DI Ltd. profitable? Cellebrite DI Ltd. earned $6.4 M of net profit in the Jun 2026 quarter, −67.3% on the same quarter a year earlier. Full-year FY25 profit was $77.8 M. Over 4 years profit has grown 2.5% a year on average. That is 4.9% of the quarter's revenue. The same quarter a year earlier earned $19.5 M. 4 of the last 12 reported quarters were loss-making. Why profit moved: revenue changed +15.8% on a year earlier and the margin moved −7.4 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −32.2% and revenue +17.8%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Cellebrite DI Ltd. make, and is it growing? Cellebrite DI Ltd. reported $131 M of revenue in the Jun 2026 quarter, +15.8% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 17.9% a year on average. The last full year, FY25, came in at $476 M. The last four reported quarters add to $514 M. FY25 revenue was $476 M, +18.6% on the year before. Recent pace: the last four quarters grew +17.8% on average, against 17.9% a year over the longer run, so this year is growing at about the same pace as its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +17.8%, against +19.1% a year over the last 8 quarters (stabilising). ## How much of every $100 of sales does Cellebrite DI Ltd. keep? Cellebrite DI Ltd.'s operating margin was 5.3% in the Jun 2026 quarter, 7.4 percentage points lower than the same quarter a year ago. Across 5 years it has been between 0.4% and 14.2%. The latest quarter is within that range. Why the margin moved: operating margin changed −7.4 percentage points on the year while gross margin changed −3.6 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Cellebrite DI Ltd.'s profit turning into cash? Over the last 3 years, 87% of Cellebrite DI Ltd.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $174 M of operating cash against $77.8 M of profit. After $13.2 M of spending on assets, $160 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Cellebrite DI Ltd.'s cash go? Cellebrite DI Ltd. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $27.0 M on assets over the last 3 years. Averaged over those years that is 1.9% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $27.0 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Cellebrite DI Ltd.'s P/E ratio, and how does it compare with its own history? Cellebrite DI Ltd.'s P/E is 53.4×, in the middle of its own history: higher than 61% of past readings. Its usual P/E (the middle reading) is 48.9×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Where the price move came from: over 3 years the price moved +18.9% a year; about +36.9% a year came from earnings growth and about −18.0 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Cellebrite DI Ltd. business getting better or worse? Cellebrite DI Ltd.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Cellebrite DI Ltd. earn on its capital? Cellebrite DI Ltd. earned a ROE of 16% in FY25. That is up from a low of −237% in FY23. Its return on capital used (ROIC) is 28.6 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 16.4% net margin and 0.51× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 16.4% net margin × 0.51× asset turnover × 1.94× leverage (assets divided by equity) ≈ 16.2% on equity. The margin does most of the work; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 39.0% − 10.4% = +28.6 percentage points. The 10.4% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value. The 39.0% ROIC above is the latest reading, as reported. The yearly chart below shows FY22 at 3.6%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Cellebrite DI Ltd. have too much debt? Cellebrite DI Ltd. has total debt of $23.2 M against shareholder equity of $538 M as of Jun 2026, so its debt is 0.04× its equity, which is very little. Year by year, that ratio went from 0.21 in FY22 to 0.05 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Cellebrite DI Ltd. shareholding pattern? 7.3% of Cellebrite DI Ltd.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 2.9 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Cellebrite DI Ltd. from balance-sheet trouble? For Cellebrite DI Ltd., the Z-score is 5.88. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 5.88 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Cellebrite DI Ltd. rank in its industry? There is no score against its industry: Cellebrite DI Ltd. is not among the largest members shown in this industry comparison for Software - Infrastructure. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Cellebrite DI Ltd. compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Cellebrite DI Ltd. in size? Cellebrite DI Ltd. is the 56th largest of 117 Software - Infrastructure companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Shift4 Payments, Inc., Teradata Corporation and Wix.com. Just below it: NetScout Systems, Inc., Five9, Inc. and Euronet Worldwide, Inc. ### Software - Infrastructure companies close in size

1. [Shift4 Payments, Inc.](https://www.sectoralpha.in/us/stocks/four) $3.3 billion
2. [Teradata Corporation](https://www.sectoralpha.in/us/stocks/tdc) $3.1 billion
3. [Wix.com Ltd.](https://www.sectoralpha.in/us/stocks/wix) $3.1 billion
4. Cellebrite DI Ltd. $3.1 billion
5. [NetScout Systems, Inc.](https://www.sectoralpha.in/us/stocks/ntct) $2.8 billion
6. [Five9, Inc.](https://www.sectoralpha.in/us/stocks/fivn) $2.7 billion
7. [Euronet Worldwide, Inc.](https://www.sectoralpha.in/us/stocks/eeft) $2.5 billion

[All 117 Software - Infrastructure companies, largest first](https://www.sectoralpha.in/us/sectors/software-infrastructure#all-companies)

### Companies close in size in other industries

1. [AtriCure, Inc.](https://www.sectoralpha.in/us/stocks/atrc) $3 billion · Medical Instruments & Supplies
2. [Ero Copper Corp.](https://www.sectoralpha.in/us/stocks/ero) $3 billion · Copper
3. Cellebrite DI Ltd. $3 billion
4. [CBIZ, Inc.](https://www.sectoralpha.in/us/stocks/cbz) $3 billion · Specialty Business Services
5. [The Marzetti Company](https://www.sectoralpha.in/us/stocks/mzti) $3 billion · Packaged Foods

## What else do people ask about Cellebrite DI Ltd.? ### What were Cellebrite DI Ltd. Ltd.'s latest quarterly results? Cellebrite DI Ltd. reported revenue of $131 M and net profit of $6.4 M for the Jun 2026 quarter. Revenue rose 15.8% and profit fell 67.3% compared with a year earlier. Earnings per share were $0.03. The operating margin was 5.3%, 7.4 percentage points lower than a year earlier (as of 3 November 2026). ### What is Cellebrite DI Ltd. Ltd.'s market cap? Cellebrite DI Ltd.'s market capitalisation is $3.1 B at a stock price of $12.25. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Cellebrite DI Ltd. Ltd. performing? Cellebrite DI Ltd.'s share price has been falling for 13 weeks. In its latest quarter, revenue rose 15.8% and profit fell 67.3% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 13 weeks running (as of 3 November 2026). ### Will Cellebrite DI Ltd. Ltd.'s stock price go up? This page does not forecast Cellebrite DI Ltd.'s stock price. What it shows instead: the stock price is $12.25, and it has been falling for 13 weeks. Its P/E of 53.4× is higher than 61% of its own last 5 years (as of 3 November 2026). ### Where is Cellebrite DI Ltd. Ltd. in its business cycle? Cellebrite DI Ltd.'s FY25 operating margin was 14.0%, against a 5-year range of 0.4% to 14.2%: the middle of its own range, neither a peak nor a low. The latest quarter was 5.3%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Cellebrite DI Ltd. Ltd. story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Cellebrite DI Ltd. Ltd. a stock worth studying right now? What the numbers show: Cellebrite DI Ltd.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- US tech stocks: https://www.sectoralpha.in/us-tech-stocks

This is research, not advice. We’re not SEBI-registered.